We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Victory Capital Holdings
VCTR
$6.65B
| $5.96M | ﹤0.01% |
255,628
+21,667
| +9% | +$575K |
|
1777
Krystal Biotech
KRYS
$9.66B
| $5.95M | ﹤0.01% |
85,325
-31
| -0% | -$2.24K |
|
1778
Oceaneering
OII
$4.77B
| $5.94M | ﹤0.01% |
746,152
+289,725
| +63% | +$2.72M |
|
1779
Xencor
XNCR
$1.55B
| $5.91M | ﹤0.01% |
227,384
+17,149
| +8% | +$491K |
|
1780
Cars.com
CARS
$660M
| $5.9M | ﹤0.01% |
513,289
-145,325
| -22% | -$1.72M |
|
1781
ADT
ADT
$5.58B
| $5.9M | ﹤0.01% |
787,815
+14,207
| +2% | +$107K |
|
|
LPRO
1782
DELISTED
Open Lending Corp
LPRO
| $5.9M | ﹤0.01% |
733,371
-12,667
| -2% | -$128K |
|
|
ACH
1783
Accendra Health
ACH
$214M
| $5.89M | ﹤0.01% |
244,462
-199,543
| -45% | -$6.15M |
|
|
VSXY
1784
Victoria's Secret
VSXY
$7.83B
| $5.88M | ﹤0.01% |
201,981
-12,970
| -6% | -$437K |
|
|
VRTV
1785
DELISTED
VERITIV CORPORATION
VRTV
| $5.88M | ﹤0.01% |
60,160
-1,790
| -3% | -$213K |
|
1786
FIGS
FIGS
$2.37B
| $5.88M | ﹤0.01% |
712,144
+222,534
| +45% | +$2.37M |
|
|
CVGW
1787
DELISTED
Calavo Growers
CVGW
| $5.87M | ﹤0.01% |
184,977
+48,753
| +36% | +$1.96M |
|
1788
Liberty Latin America Class C
LILAK
$1.64B
| $5.87M | ﹤0.01% |
1,049,393
-451,605
| -30% | -$2.91M |
|
1789
Crinetics Pharmaceuticals
CRNX
$8.92B
| $5.83M | ﹤0.01% |
296,591
-105,419
| -26% | -$2.15M |
|
1790
Fate Therapeutics
FATE
$326M
| $5.83M | ﹤0.01% |
259,950
-172,300
| -40% | -$4.98M |
|
1791
MillerKnoll
MLKN
$1.67B
| $5.81M | ﹤0.01% |
372,518
-348,499
| -48% | -$9.58M |
|
1792
AnaptysBio
ANAB
$1.68B
| $5.81M | ﹤0.01% |
227,782
-24,022
| -10% | -$563K |
|
|
WSR
1793
DELISTED
Whitestone REIT
WSR
| $5.8M | ﹤0.01% |
685,837
-79,669
| -10% | -$818K |
|
1794
Northwest Bancshares
NWBI
$2.28B
| $5.79M | ﹤0.01% |
428,457
-259,514
| -38% | -$3.61M |
|
1795
Pilgrim's Pride
PPC
$6.54B
| $5.78M | ﹤0.01% |
251,264
-32,316
| -11% | -$934K |
|
|
FBC
1796
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $5.77M | ﹤0.01% |
172,636
-4,477
| -3% | -$171K |
|
1797
JetBlue
JBLU
$2.29B
| $5.76M | ﹤0.01% |
869,284
-47,972
| -5% | -$391K |
|
|
JWN
1798
DELISTED
Nordstrom
JWN
| $5.75M | ﹤0.01% |
343,998
-14,613
| -4% | -$305K |
|
|
ICPT
1799
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $5.75M | ﹤0.01% |
412,026
+94,515
| +30% | +$1.52M |
|
1800
Camping World
CWH
$653M
| $5.74M | ﹤0.01% |
226,683
-24,685
| -10% | -$686K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.